

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neuron cell-cell adhesion (GO:0007158) | 5.99918120 |
| 2 | vocalization behavior (GO:0071625) | 5.41416803 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.35895898 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.34216831 |
| 5 | fucose catabolic process (GO:0019317) | 5.25301631 |
| 6 | L-fucose metabolic process (GO:0042354) | 5.25301631 |
| 7 | L-fucose catabolic process (GO:0042355) | 5.25301631 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.22746599 |
| 9 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.20528834 |
| 10 | synaptic vesicle maturation (GO:0016188) | 5.13933317 |
| 11 | synaptic vesicle exocytosis (GO:0016079) | 5.09615599 |
| 12 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.01130083 |
| 13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.91301881 |
| 14 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.89454258 |
| 15 | glutamate secretion (GO:0014047) | 4.77663003 |
| 16 | protein localization to synapse (GO:0035418) | 4.77588262 |
| 17 | layer formation in cerebral cortex (GO:0021819) | 4.67838141 |
| 18 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.66887261 |
| 19 | locomotory exploration behavior (GO:0035641) | 4.63775973 |
| 20 | neuron recognition (GO:0008038) | 4.54974221 |
| 21 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.52596126 |
| 22 | cell migration in hindbrain (GO:0021535) | 4.39928620 |
| 23 | startle response (GO:0001964) | 4.39088548 |
| 24 | presynaptic membrane assembly (GO:0097105) | 4.37860143 |
| 25 | postsynaptic membrane organization (GO:0001941) | 4.35344508 |
| 26 | dendritic spine morphogenesis (GO:0060997) | 4.35215871 |
| 27 | nucleobase catabolic process (GO:0046113) | 4.31836449 |
| 28 | glutamate receptor signaling pathway (GO:0007215) | 4.28711879 |
| 29 | regulation of synaptic vesicle transport (GO:1902803) | 4.25141155 |
| 30 | exploration behavior (GO:0035640) | 4.19580929 |
| 31 | regulation of synapse structural plasticity (GO:0051823) | 4.17823726 |
| 32 | auditory behavior (GO:0031223) | 4.11468265 |
| 33 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.10772765 |
| 34 | axonal fasciculation (GO:0007413) | 4.09100924 |
| 35 | gamma-aminobutyric acid transport (GO:0015812) | 4.06306375 |
| 36 | proline transport (GO:0015824) | 4.01844310 |
| 37 | neurotransmitter secretion (GO:0007269) | 3.94522978 |
| 38 | presynaptic membrane organization (GO:0097090) | 3.90917243 |
| 39 | synaptic transmission, glutamatergic (GO:0035249) | 3.90132933 |
| 40 | dendrite morphogenesis (GO:0048813) | 3.89765406 |
| 41 | positive regulation of synapse maturation (GO:0090129) | 3.88129950 |
| 42 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.79527927 |
| 43 | spinal cord development (GO:0021510) | 3.79292830 |
| 44 | neuron-neuron synaptic transmission (GO:0007270) | 3.75717617 |
| 45 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.74859528 |
| 46 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.73951056 |
| 47 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.72333688 |
| 48 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.69671172 |
| 49 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.68266951 |
| 50 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.63463223 |
| 51 | establishment of mitochondrion localization (GO:0051654) | 3.60712828 |
| 52 | positive regulation of membrane potential (GO:0045838) | 3.58737887 |
| 53 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.57409777 |
| 54 | mitochondrion transport along microtubule (GO:0047497) | 3.57409777 |
| 55 | cerebellar granule cell differentiation (GO:0021707) | 3.57115587 |
| 56 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.56041016 |
| 57 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.55570263 |
| 58 | negative regulation of microtubule polymerization (GO:0031115) | 3.54882261 |
| 59 | retinal ganglion cell axon guidance (GO:0031290) | 3.50022639 |
| 60 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.48870195 |
| 61 | regulation of vesicle fusion (GO:0031338) | 3.48050545 |
| 62 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.43676528 |
| 63 | axon extension (GO:0048675) | 3.41978829 |
| 64 | synapse assembly (GO:0007416) | 3.41899386 |
| 65 | regulation of postsynaptic membrane potential (GO:0060078) | 3.41328363 |
| 66 | neuronal action potential propagation (GO:0019227) | 3.38319618 |
| 67 | positive regulation of synapse assembly (GO:0051965) | 3.35497677 |
| 68 | long-term memory (GO:0007616) | 3.33937212 |
| 69 | regulation of neurotransmitter secretion (GO:0046928) | 3.32162881 |
| 70 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.31441048 |
| 71 | mechanosensory behavior (GO:0007638) | 3.31415855 |
| 72 | activation of protein kinase A activity (GO:0034199) | 3.30885469 |
| 73 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 3.30003424 |
| 74 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.28462316 |
| 75 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.26865013 |
| 76 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.25563077 |
| 77 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.25301884 |
| 78 | neurofilament cytoskeleton organization (GO:0060052) | 3.24133993 |
| 79 | organelle transport along microtubule (GO:0072384) | 3.22677673 |
| 80 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.22075852 |
| 81 | transmission of nerve impulse (GO:0019226) | 3.21828866 |
| 82 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.21026268 |
| 83 | nonmotile primary cilium assembly (GO:0035058) | 3.20323124 |
| 84 | neurotransmitter transport (GO:0006836) | 3.19493082 |
| 85 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.18649639 |
| 86 | dopamine receptor signaling pathway (GO:0007212) | 3.17219584 |
| 87 | innervation (GO:0060384) | 3.17182268 |
| 88 | regulation of synapse maturation (GO:0090128) | 3.16123016 |
| 89 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.15291135 |
| 90 | clathrin coat assembly (GO:0048268) | 3.09311012 |
| 91 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.09178575 |
| 92 | regulation of dendritic spine development (GO:0060998) | 3.08042853 |
| 93 | regulation of synaptic plasticity (GO:0048167) | 3.03799157 |
| 94 | hindbrain development (GO:0030902) | 3.03296099 |
| 95 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.02906093 |
| 96 | response to histamine (GO:0034776) | 3.01160410 |
| 97 | somite development (GO:0061053) | 3.00736310 |
| 98 | neuron projection extension (GO:1990138) | 3.00639196 |
| 99 | behavioral response to nicotine (GO:0035095) | 2.98828676 |
| 100 | fucosylation (GO:0036065) | 2.98746359 |
| 101 | membrane depolarization (GO:0051899) | 2.97906025 |
| 102 | membrane hyperpolarization (GO:0060081) | 2.96618326 |
| 103 | positive regulation of dendritic spine development (GO:0060999) | 2.96299389 |
| 104 | long-term synaptic potentiation (GO:0060291) | 2.94958822 |
| 105 | synaptic vesicle endocytosis (GO:0048488) | 2.93800734 |
| 106 | regulation of synapse assembly (GO:0051963) | 2.93471492 |
| 107 | synapse organization (GO:0050808) | 2.93001752 |
| 108 | neuromuscular process controlling balance (GO:0050885) | 2.92739621 |
| 109 | regulation of synapse organization (GO:0050807) | 2.92471461 |
| 110 | regulation of neurotransmitter transport (GO:0051588) | 2.92006766 |
| 111 | ribonucleoprotein complex disassembly (GO:0032988) | 2.91729704 |
| 112 | mating behavior (GO:0007617) | 2.91696840 |
| 113 | membrane depolarization during action potential (GO:0086010) | 2.89763679 |
| 114 | dendrite development (GO:0016358) | 2.89552765 |
| 115 | negative regulation of dendrite development (GO:2000171) | 2.89079372 |
| 116 | spinal cord association neuron differentiation (GO:0021527) | 2.87452859 |
| 117 | social behavior (GO:0035176) | 2.87126408 |
| 118 | intraspecies interaction between organisms (GO:0051703) | 2.87126408 |
| 119 | central nervous system neuron axonogenesis (GO:0021955) | 2.87089463 |
| 120 | response to auditory stimulus (GO:0010996) | 2.81273420 |
| 121 | limb bud formation (GO:0060174) | 2.76970278 |
| 122 | serotonin metabolic process (GO:0042428) | 2.74358437 |
| 123 | response to pheromone (GO:0019236) | 2.73220928 |
| 124 | limb development (GO:0060173) | 2.71599485 |
| 125 | appendage development (GO:0048736) | 2.71599485 |
| 126 | protein localization to cilium (GO:0061512) | 2.71062586 |
| 127 | positive regulation of amino acid transport (GO:0051957) | 2.65135450 |
| 128 | forebrain neuron differentiation (GO:0021879) | 2.64987818 |
| 129 | glycosphingolipid biosynthetic process (GO:0006688) | 2.63747935 |
| 130 | intraciliary transport (GO:0042073) | 2.62750071 |
| 131 | epithelial cilium movement (GO:0003351) | 2.60985847 |
| 132 | axonemal dynein complex assembly (GO:0070286) | 2.60666752 |
| 133 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.60203126 |
| 134 | primary amino compound metabolic process (GO:1901160) | 2.58026395 |
| 135 | neuronal stem cell maintenance (GO:0097150) | 2.57222459 |
| 136 | fucose metabolic process (GO:0006004) | 2.53793317 |
| 137 | neuronal ion channel clustering (GO:0045161) | 2.49540739 |
| 138 | * homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) | 2.49058421 |
| 139 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.47283445 |
| 140 | axon extension involved in axon guidance (GO:0048846) | 2.47283445 |
| 141 | neuronal action potential (GO:0019228) | 2.45493029 |
| 142 | neurotransmitter catabolic process (GO:0042135) | 2.43914932 |
| 143 | otic vesicle formation (GO:0030916) | 2.42978328 |
| 144 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157) | 2.40389169 |
| 145 | regulation of pigment cell differentiation (GO:0050932) | 2.38565360 |
| 146 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.38387449 |
| 147 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.38387449 |
| 148 | ganglion development (GO:0061548) | 2.36493148 |
| 149 | adult walking behavior (GO:0007628) | 2.35764190 |
| 150 | chemosensory behavior (GO:0007635) | 2.35260356 |
| 151 | negative chemotaxis (GO:0050919) | 2.29507483 |
| 152 | positive regulation of gastrulation (GO:2000543) | 2.28967957 |
| 153 | positive regulation of developmental pigmentation (GO:0048087) | 2.27908647 |
| 154 | negative regulation of appetite (GO:0032099) | 2.27906071 |
| 155 | negative regulation of response to food (GO:0032096) | 2.27906071 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.28164555 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.84978299 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.08846592 |
| 4 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.05225041 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.96816713 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.71291388 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.59489158 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.59489158 |
| 9 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.57583751 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.56202823 |
| 11 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.54906052 |
| 12 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.53276472 |
| 13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.51928421 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.41278845 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.40829154 |
| 16 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.36453114 |
| 17 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.34765155 |
| 18 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.34641666 |
| 19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.31009466 |
| 20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.25077732 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.22670200 |
| 22 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.20050907 |
| 23 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.19921538 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.18036374 |
| 25 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.15041825 |
| 26 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.13618571 |
| 27 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.09598466 |
| 28 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.04647632 |
| 29 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.04513913 |
| 30 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.01434583 |
| 31 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.00253291 |
| 32 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.90445390 |
| 33 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.81769564 |
| 34 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.79503778 |
| 35 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.79458070 |
| 36 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.72944978 |
| 37 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.72383938 |
| 38 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.65769116 |
| 39 | EWS_26573619_Chip-Seq_HEK293_Human | 1.64577590 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.63792827 |
| 41 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.61671217 |
| 42 | P300_19829295_ChIP-Seq_ESCs_Human | 1.56150700 |
| 43 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.54968646 |
| 44 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.53878365 |
| 45 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.51099396 |
| 46 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.47735626 |
| 47 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.45840340 |
| 48 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.44964199 |
| 49 | VDR_22108803_ChIP-Seq_LS180_Human | 1.44816434 |
| 50 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.44795138 |
| 51 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.44684295 |
| 52 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.43506040 |
| 53 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.42937284 |
| 54 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.42747545 |
| 55 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.40706372 |
| 56 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.39899732 |
| 57 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.36376803 |
| 58 | FUS_26573619_Chip-Seq_HEK293_Human | 1.35870554 |
| 59 | AR_25329375_ChIP-Seq_VCAP_Human | 1.34837262 |
| 60 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.34218563 |
| 61 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.33646951 |
| 62 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.30574812 |
| 63 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.29210168 |
| 64 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.28659574 |
| 65 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28210600 |
| 66 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.27523138 |
| 67 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.27283799 |
| 68 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.25748018 |
| 69 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.25045176 |
| 70 | STAT3_23295773_ChIP-Seq_U87_Human | 1.23901114 |
| 71 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.23004371 |
| 72 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.21094626 |
| 73 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.19503781 |
| 74 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.19272863 |
| 75 | TCF4_23295773_ChIP-Seq_U87_Human | 1.16925231 |
| 76 | AR_19668381_ChIP-Seq_PC3_Human | 1.16750536 |
| 77 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16199909 |
| 78 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.16199909 |
| 79 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.15884131 |
| 80 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.15135027 |
| 81 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.14310577 |
| 82 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14243340 |
| 83 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.13989834 |
| 84 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13971507 |
| 85 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.13798008 |
| 86 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.09172213 |
| 87 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.07775743 |
| 88 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07374547 |
| 89 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.06570389 |
| 90 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.06516416 |
| 91 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.06267385 |
| 92 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.05861752 |
| 93 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.05574817 |
| 94 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.05300368 |
| 95 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04994875 |
| 96 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.04512530 |
| 97 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.03990123 |
| 98 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03532469 |
| 99 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.03092817 |
| 100 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.02458256 |
| 101 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.02343009 |
| 102 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00415203 |
| 103 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.99584847 |
| 104 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.99584847 |
| 105 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99115745 |
| 106 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.98995053 |
| 107 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.98550049 |
| 108 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98430022 |
| 109 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.97492103 |
| 110 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.97309478 |
| 111 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95566178 |
| 112 | JUN_21703547_ChIP-Seq_K562_Human | 0.94953580 |
| 113 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.94823423 |
| 114 | TP53_16413492_ChIP-PET_HCT116_Human | 0.94777069 |
| 115 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.93066848 |
| 116 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.92637694 |
| 117 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90571354 |
| 118 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.90543280 |
| 119 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.90403698 |
| 120 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.90032737 |
| 121 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.89265440 |
| 122 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.87054787 |
| 123 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.86865751 |
| 124 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.86682243 |
| 125 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.86351093 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.46012440 |
| 2 | MP0003136_yellow_coat_color | 4.88567628 |
| 3 | MP0003880_abnormal_central_pattern | 4.55358791 |
| 4 | MP0004270_analgesia | 4.02526428 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 4.00061493 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.26999275 |
| 7 | MP0005423_abnormal_somatic_nervous | 3.22331735 |
| 8 | MP0001968_abnormal_touch/_nociception | 3.19122838 |
| 9 | MP0009745_abnormal_behavioral_response | 3.08871706 |
| 10 | MP0002734_abnormal_mechanical_nocicepti | 2.90969622 |
| 11 | MP0002064_seizures | 2.89106491 |
| 12 | MP0009046_muscle_twitch | 2.88769397 |
| 13 | MP0002735_abnormal_chemical_nociception | 2.79457692 |
| 14 | MP0002572_abnormal_emotion/affect_behav | 2.69190875 |
| 15 | MP0003283_abnormal_digestive_organ | 2.68019521 |
| 16 | MP0000778_abnormal_nervous_system | 2.61272424 |
| 17 | MP0002733_abnormal_thermal_nociception | 2.57277167 |
| 18 | MP0002736_abnormal_nociception_after | 2.52104582 |
| 19 | MP0001486_abnormal_startle_reflex | 2.39885103 |
| 20 | MP0001440_abnormal_grooming_behavior | 2.34083999 |
| 21 | MP0006276_abnormal_autonomic_nervous | 2.33990653 |
| 22 | MP0002272_abnormal_nervous_system | 2.27357334 |
| 23 | MP0002184_abnormal_innervation | 2.22672903 |
| 24 | MP0001970_abnormal_pain_threshold | 2.17709818 |
| 25 | MP0000569_abnormal_digit_pigmentation | 2.16599656 |
| 26 | MP0003329_amyloid_beta_deposits | 2.07399465 |
| 27 | MP0002938_white_spotting | 2.05252256 |
| 28 | MP0002067_abnormal_sensory_capabilities | 2.05142391 |
| 29 | MP0005386_behavior/neurological_phenoty | 2.04750050 |
| 30 | MP0004924_abnormal_behavior | 2.04750050 |
| 31 | MP0003890_abnormal_embryonic-extraembry | 1.98626550 |
| 32 | MP0004133_heterotaxia | 1.97096996 |
| 33 | MP0002557_abnormal_social/conspecific_i | 1.96579788 |
| 34 | MP0004858_abnormal_nervous_system | 1.94872845 |
| 35 | MP0000566_synostosis | 1.94743332 |
| 36 | MP0001986_abnormal_taste_sensitivity | 1.86853112 |
| 37 | MP0001984_abnormal_olfaction | 1.82613590 |
| 38 | MP0004811_abnormal_neuron_physiology | 1.80616987 |
| 39 | MP0008995_early_reproductive_senescence | 1.80229590 |
| 40 | MP0001501_abnormal_sleep_pattern | 1.77334046 |
| 41 | MP0003119_abnormal_digestive_system | 1.74644035 |
| 42 | MP0000955_abnormal_spinal_cord | 1.69507810 |
| 43 | MP0002102_abnormal_ear_morphology | 1.68314687 |
| 44 | MP0001529_abnormal_vocalization | 1.68037209 |
| 45 | MP0003787_abnormal_imprinting | 1.68001712 |
| 46 | MP0002822_catalepsy | 1.58480499 |
| 47 | MP0002638_abnormal_pupillary_reflex | 1.56717509 |
| 48 | MP0002882_abnormal_neuron_morphology | 1.54236364 |
| 49 | MP0008569_lethality_at_weaning | 1.52426100 |
| 50 | MP0009780_abnormal_chondrocyte_physiolo | 1.49106796 |
| 51 | MP0001293_anophthalmia | 1.46229570 |
| 52 | MP0002066_abnormal_motor_capabilities/c | 1.45145201 |
| 53 | MP0000537_abnormal_urethra_morphology | 1.43191938 |
| 54 | MP0003315_abnormal_perineum_morphology | 1.42414055 |
| 55 | MP0010030_abnormal_orbit_morphology | 1.42114785 |
| 56 | MP0002909_abnormal_adrenal_gland | 1.41495294 |
| 57 | MP0003879_abnormal_hair_cell | 1.36380579 |
| 58 | MP0005645_abnormal_hypothalamus_physiol | 1.31862022 |
| 59 | MP0002152_abnormal_brain_morphology | 1.27620695 |
| 60 | MP0005171_absent_coat_pigmentation | 1.22792184 |
| 61 | MP0000534_abnormal_ureter_morphology | 1.22668158 |
| 62 | MP0009379_abnormal_foot_pigmentation | 1.20321234 |
| 63 | MP0004885_abnormal_endolymph | 1.20019371 |
| 64 | MP0004142_abnormal_muscle_tone | 1.19559752 |
| 65 | MP0005551_abnormal_eye_electrophysiolog | 1.18673035 |
| 66 | MP0001502_abnormal_circadian_rhythm | 1.17334807 |
| 67 | MP0003123_paternal_imprinting | 1.12837702 |
| 68 | MP0000049_abnormal_middle_ear | 1.12169303 |
| 69 | MP0003633_abnormal_nervous_system | 1.11995246 |
| 70 | MP0000427_abnormal_hair_cycle | 1.10225140 |
| 71 | MP0003122_maternal_imprinting | 1.07997951 |
| 72 | MP0001905_abnormal_dopamine_level | 1.07972770 |
| 73 | MP0005394_taste/olfaction_phenotype | 1.06191083 |
| 74 | MP0005499_abnormal_olfactory_system | 1.06191083 |
| 75 | MP0004742_abnormal_vestibular_system | 1.05377782 |
| 76 | MP0000751_myopathy | 1.05231077 |
| 77 | MP0001188_hyperpigmentation | 1.04297875 |
| 78 | MP0003631_nervous_system_phenotype | 1.00776204 |
| 79 | MP0002069_abnormal_eating/drinking_beha | 0.99657901 |
| 80 | MP0002229_neurodegeneration | 0.99008079 |
| 81 | MP0003937_abnormal_limbs/digits/tail_de | 0.97819133 |
| 82 | MP0002752_abnormal_somatic_nervous | 0.96614136 |
| 83 | MP0005253_abnormal_eye_physiology | 0.94516640 |
| 84 | MP0002233_abnormal_nose_morphology | 0.94363524 |
| 85 | MP0002653_abnormal_ependyma_morphology | 0.93307029 |
| 86 | MP0002697_abnormal_eye_size | 0.92399534 |
| 87 | MP0000631_abnormal_neuroendocrine_gland | 0.92248927 |
| 88 | MP0005646_abnormal_pituitary_gland | 0.90540396 |
| 89 | MP0003634_abnormal_glial_cell | 0.90518606 |
| 90 | MP0003861_abnormal_nervous_system | 0.90114907 |
| 91 | MP0000604_amyloidosis | 0.89915138 |
| 92 | MP0001324_abnormal_eye_pigmentation | 0.88843572 |
| 93 | MP0003878_abnormal_ear_physiology | 0.88461142 |
| 94 | MP0005377_hearing/vestibular/ear_phenot | 0.88461142 |
| 95 | MP0003942_abnormal_urinary_system | 0.88200383 |
| 96 | MP0000462_abnormal_digestive_system | 0.87608564 |
| 97 | MP0010386_abnormal_urinary_bladder | 0.86120785 |
| 98 | MP0005195_abnormal_posterior_eye | 0.85763056 |
| 99 | MP0006072_abnormal_retinal_apoptosis | 0.84951689 |
| 100 | MP0005367_renal/urinary_system_phenotyp | 0.84758171 |
| 101 | MP0000516_abnormal_urinary_system | 0.84758171 |
| 102 | MP0000026_abnormal_inner_ear | 0.84658382 |
| 103 | MP0001348_abnormal_lacrimal_gland | 0.84549007 |
| 104 | MP0004085_abnormal_heartbeat | 0.82840579 |
| 105 | MP0002751_abnormal_autonomic_nervous | 0.81587003 |
| 106 | MP0004215_abnormal_myocardial_fiber | 0.79189231 |
| 107 | MP0006292_abnormal_olfactory_placode | 0.78722722 |
| 108 | MP0008874_decreased_physiological_sensi | 0.78593583 |
| 109 | MP0001286_abnormal_eye_development | 0.77415130 |
| 110 | MP0001963_abnormal_hearing_physiology | 0.77411613 |
| 111 | MP0003632_abnormal_nervous_system | 0.76650008 |
| 112 | MP0005248_abnormal_Harderian_gland | 0.75872819 |
| 113 | MP0005391_vision/eye_phenotype | 0.75448381 |
| 114 | MP0008961_abnormal_basal_metabolism | 0.75297878 |
| 115 | MP0003941_abnormal_skin_development | 0.73829925 |
| 116 | MP0008872_abnormal_physiological_respon | 0.71530317 |
| 117 | MP0002090_abnormal_vision | 0.70623036 |
| 118 | MP0001177_atelectasis | 0.67763531 |
| 119 | MP0002876_abnormal_thyroid_physiology | 0.67074046 |
| 120 | MP0008789_abnormal_olfactory_epithelium | 0.66798349 |
| 121 | MP0003137_abnormal_impulse_conducting | 0.66716687 |
| 122 | MP0002234_abnormal_pharynx_morphology | 0.63457263 |
| 123 | MP0002837_dystrophic_cardiac_calcinosis | 0.63346837 |
| 124 | MP0010770_preweaning_lethality | 0.63141331 |
| 125 | MP0002082_postnatal_lethality | 0.63141331 |
| 126 | MP0004145_abnormal_muscle_electrophysio | 0.61884131 |
| 127 | MP0000920_abnormal_myelination | 0.61600493 |
| 128 | MP0001299_abnormal_eye_distance/ | 0.61582026 |
| 129 | MP0010769_abnormal_survival | 0.61050599 |
| 130 | MP0004233_abnormal_muscle_weight | 0.59741329 |
| 131 | MP0004484_altered_response_of | 0.59391190 |
| 132 | MP0010768_mortality/aging | 0.56820171 |
| 133 | MP0003121_genomic_imprinting | 0.55939688 |
| 134 | MP0005187_abnormal_penis_morphology | 0.55755850 |
| 135 | MP0001943_abnormal_respiration | 0.55749588 |
| 136 | MP0003938_abnormal_ear_development | 0.54866218 |
| 137 | MP0003956_abnormal_body_size | 0.54580771 |
| 138 | MP0005623_abnormal_meninges_morphology | 0.54450765 |
| 139 | MP0005448_abnormal_energy_balance | 0.54347684 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.96667391 |
| 2 | Epileptic encephalopathy (HP:0200134) | 5.67013800 |
| 3 | Myokymia (HP:0002411) | 5.60344655 |
| 4 | Focal seizures (HP:0007359) | 5.22325242 |
| 5 | Visual hallucinations (HP:0002367) | 4.68039901 |
| 6 | Febrile seizures (HP:0002373) | 3.87802283 |
| 7 | Atonic seizures (HP:0010819) | 3.86802671 |
| 8 | Mutism (HP:0002300) | 3.74659708 |
| 9 | Progressive cerebellar ataxia (HP:0002073) | 3.72741113 |
| 10 | Excessive salivation (HP:0003781) | 3.64274302 |
| 11 | Drooling (HP:0002307) | 3.64274302 |
| 12 | Abnormality of the corticospinal tract (HP:0002492) | 3.62119994 |
| 13 | Amyotrophic lateral sclerosis (HP:0007354) | 3.58178536 |
| 14 | Supranuclear gaze palsy (HP:0000605) | 3.52797171 |
| 15 | Poor eye contact (HP:0000817) | 3.49085077 |
| 16 | Broad-based gait (HP:0002136) | 3.47569458 |
| 17 | Generalized tonic-clonic seizures (HP:0002069) | 3.47141145 |
| 18 | Hyperventilation (HP:0002883) | 3.34399592 |
| 19 | Absence seizures (HP:0002121) | 3.33044670 |
| 20 | Amblyopia (HP:0000646) | 3.25061901 |
| 21 | Epileptiform EEG discharges (HP:0011182) | 3.15052133 |
| 22 | Neurofibrillary tangles (HP:0002185) | 3.11562761 |
| 23 | EEG with generalized epileptiform discharges (HP:0011198) | 3.11559087 |
| 24 | Polyphagia (HP:0002591) | 3.11223851 |
| 25 | Cerebral inclusion bodies (HP:0100314) | 3.09936832 |
| 26 | Dialeptic seizures (HP:0011146) | 3.07514109 |
| 27 | Ankle clonus (HP:0011448) | 3.07371077 |
| 28 | Impaired social interactions (HP:0000735) | 3.06304470 |
| 29 | Abnormal social behavior (HP:0012433) | 3.06304470 |
| 30 | Hypsarrhythmia (HP:0002521) | 2.99304101 |
| 31 | Limb dystonia (HP:0002451) | 2.95104220 |
| 32 | Abnormal eating behavior (HP:0100738) | 2.92086844 |
| 33 | Insidious onset (HP:0003587) | 2.91793877 |
| 34 | Termporal pattern (HP:0011008) | 2.91793877 |
| 35 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.90883203 |
| 36 | Truncal ataxia (HP:0002078) | 2.90684241 |
| 37 | Action tremor (HP:0002345) | 2.89863900 |
| 38 | Septo-optic dysplasia (HP:0100842) | 2.87190442 |
| 39 | Akinesia (HP:0002304) | 2.84892532 |
| 40 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.84699572 |
| 41 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.84699572 |
| 42 | Myelomeningocele (HP:0002475) | 2.79971807 |
| 43 | Abnormality of the lower motor neuron (HP:0002366) | 2.64435630 |
| 44 | Progressive inability to walk (HP:0002505) | 2.63358856 |
| 45 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.60604978 |
| 46 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.59932353 |
| 47 | Cutaneous finger syndactyly (HP:0010554) | 2.58772559 |
| 48 | Depression (HP:0000716) | 2.56981045 |
| 49 | Ulnar claw (HP:0001178) | 2.56818511 |
| 50 | Pheochromocytoma (HP:0002666) | 2.56725206 |
| 51 | Fetal akinesia sequence (HP:0001989) | 2.56608052 |
| 52 | Spastic gait (HP:0002064) | 2.56399191 |
| 53 | Agitation (HP:0000713) | 2.52340966 |
| 54 | Inappropriate behavior (HP:0000719) | 2.52208153 |
| 55 | Urinary urgency (HP:0000012) | 2.50403779 |
| 56 | Vaginal atresia (HP:0000148) | 2.48856761 |
| 57 | Gaze-evoked nystagmus (HP:0000640) | 2.48576040 |
| 58 | Shawl scrotum (HP:0000049) | 2.47961326 |
| 59 | Hypoplastic pelvis (HP:0008839) | 2.46074422 |
| 60 | Absent speech (HP:0001344) | 2.45950260 |
| 61 | Protruding tongue (HP:0010808) | 2.43081652 |
| 62 | Genital tract atresia (HP:0001827) | 2.42991760 |
| 63 | Abnormality of salivation (HP:0100755) | 2.40265759 |
| 64 | Anxiety (HP:0000739) | 2.39571881 |
| 65 | Molar tooth sign on MRI (HP:0002419) | 2.36545065 |
| 66 | Abnormality of midbrain morphology (HP:0002418) | 2.36545065 |
| 67 | Dysdiadochokinesis (HP:0002075) | 2.36114351 |
| 68 | Abnormality of the labia minora (HP:0012880) | 2.34721833 |
| 69 | Bilateral microphthalmos (HP:0007633) | 2.34108598 |
| 70 | Hemiparesis (HP:0001269) | 2.33334957 |
| 71 | Abnormality of binocular vision (HP:0011514) | 2.31505891 |
| 72 | Diplopia (HP:0000651) | 2.31505891 |
| 73 | Absent septum pellucidum (HP:0001331) | 2.30944220 |
| 74 | Papilledema (HP:0001085) | 2.29702129 |
| 75 | Dysmetria (HP:0001310) | 2.29254448 |
| 76 | Shoulder girdle muscle weakness (HP:0003547) | 2.27477260 |
| 77 | Hypoplasia of the brainstem (HP:0002365) | 2.26710896 |
| 78 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.26710896 |
| 79 | Pendular nystagmus (HP:0012043) | 2.26469698 |
| 80 | Inability to walk (HP:0002540) | 2.26358556 |
| 81 | Scanning speech (HP:0002168) | 2.25895331 |
| 82 | Stenosis of the external auditory canal (HP:0000402) | 2.25508736 |
| 83 | Genetic anticipation (HP:0003743) | 2.22870511 |
| 84 | Anophthalmia (HP:0000528) | 2.21651820 |
| 85 | Stereotypic behavior (HP:0000733) | 2.21409219 |
| 86 | Lissencephaly (HP:0001339) | 2.20876985 |
| 87 | Nephronophthisis (HP:0000090) | 2.18905958 |
| 88 | Lower limb muscle weakness (HP:0007340) | 2.18740943 |
| 89 | Hepatoblastoma (HP:0002884) | 2.15579541 |
| 90 | Esotropia (HP:0000565) | 2.15005769 |
| 91 | Keratoconus (HP:0000563) | 2.14918773 |
| 92 | Increased corneal curvature (HP:0100692) | 2.14918773 |
| 93 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.14869993 |
| 94 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.13094041 |
| 95 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.13094041 |
| 96 | Status epilepticus (HP:0002133) | 2.12236505 |
| 97 | Neuroendocrine neoplasm (HP:0100634) | 2.11560038 |
| 98 | Cutaneous syndactyly (HP:0012725) | 2.11308904 |
| 99 | Impaired smooth pursuit (HP:0007772) | 2.10914568 |
| 100 | Apathy (HP:0000741) | 2.10897662 |
| 101 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.10043751 |
| 102 | Torticollis (HP:0000473) | 2.08978839 |
| 103 | Gait imbalance (HP:0002141) | 2.08907082 |
| 104 | Maternal diabetes (HP:0009800) | 2.08793103 |
| 105 | Pachygyria (HP:0001302) | 2.08398809 |
| 106 | Exotropia (HP:0000577) | 2.06696255 |
| 107 | Open mouth (HP:0000194) | 2.03624249 |
| 108 | Congenital primary aphakia (HP:0007707) | 2.03124783 |
| 109 | Gonadotropin excess (HP:0000837) | 2.02742160 |
| 110 | Chronic otitis media (HP:0000389) | 2.01811125 |
| 111 | Abnormality of macular pigmentation (HP:0008002) | 2.01643840 |
| 112 | Hyperthyroidism (HP:0000836) | 2.00386856 |
| 113 | Hyperglycinuria (HP:0003108) | 1.96605915 |
| 114 | Autism (HP:0000717) | 1.96465334 |
| 115 | Specific learning disability (HP:0001328) | 1.95808703 |
| 116 | Postural instability (HP:0002172) | 1.95121615 |
| 117 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.94379957 |
| 118 | Focal dystonia (HP:0004373) | 1.92588528 |
| 119 | Medial flaring of the eyebrow (HP:0010747) | 1.92280648 |
| 120 | Bifid tongue (HP:0010297) | 1.91815782 |
| 121 | Sporadic (HP:0003745) | 1.91764437 |
| 122 | Blue irides (HP:0000635) | 1.91487082 |
| 123 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.91240141 |
| 124 | Athetosis (HP:0002305) | 1.91226932 |
| 125 | Bradykinesia (HP:0002067) | 1.90790139 |
| 126 | Obstructive sleep apnea (HP:0002870) | 1.90738644 |
| 127 | Renal hypoplasia (HP:0000089) | 1.87724475 |
| 128 | Aqueductal stenosis (HP:0002410) | 1.87433710 |
| 129 | Sleep apnea (HP:0010535) | 1.87271933 |
| 130 | Hypoventilation (HP:0002791) | 1.86188218 |
| 131 | Nephrogenic diabetes insipidus (HP:0009806) | 1.85758640 |
| 132 | Generalized myoclonic seizures (HP:0002123) | 1.85592594 |
| 133 | Decreased central vision (HP:0007663) | 1.84640045 |
| 134 | Diminished motivation (HP:0000745) | 1.84638140 |
| 135 | Intestinal atresia (HP:0011100) | 1.84627087 |
| 136 | Generalized hypotonia (HP:0001290) | 1.84518691 |
| 137 | Hypothermia (HP:0002045) | 1.84022344 |
| 138 | Volvulus (HP:0002580) | 1.83790659 |
| 139 | Abnormal hair whorl (HP:0010721) | 1.83089624 |
| 140 | Abnormality of the septum pellucidum (HP:0007375) | 1.81507839 |
| 141 | Narrow forehead (HP:0000341) | 1.79950803 |
| 142 | Megalencephaly (HP:0001355) | 1.79371604 |
| 143 | Abnormality of the aortic arch (HP:0012303) | 1.78475825 |
| 144 | Vitreoretinal degeneration (HP:0000655) | 1.78376181 |
| 145 | Pancreatic fibrosis (HP:0100732) | 1.77823781 |
| 146 | Sclerocornea (HP:0000647) | 1.76695712 |
| 147 | Meningocele (HP:0002435) | 1.75339618 |
| 148 | Decreased testicular size (HP:0008734) | 1.72905593 |
| 149 | True hermaphroditism (HP:0010459) | 1.72309995 |
| 150 | Bicornuate uterus (HP:0000813) | 1.70566129 |
| 151 | Muscular hypotonia of the trunk (HP:0008936) | 1.69774572 |
| 152 | Failure to thrive in infancy (HP:0001531) | 1.69019287 |
| 153 | Pancreatic cysts (HP:0001737) | 1.68214302 |
| 154 | Scrotal hypoplasia (HP:0000046) | 1.67320292 |
| 155 | Optic nerve hypoplasia (HP:0000609) | 1.66740297 |
| 156 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.65738652 |
| 157 | Aplasia of the phalanges of the hand (HP:0009802) | 1.65738652 |
| 158 | Aplasia involving bones of the extremities (HP:0009825) | 1.65738652 |
| 159 | Thyroid-stimulating hormone excess (HP:0002925) | 1.64927246 |
| 160 | Hyperglycinemia (HP:0002154) | 1.63357126 |
| 161 | Anencephaly (HP:0002323) | 1.63139546 |
| 162 | Abnormality of the renal medulla (HP:0100957) | 1.62756584 |
| 163 | Rib fusion (HP:0000902) | 1.59014527 |
| 164 | Esophageal atresia (HP:0002032) | 1.57530144 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 6.47804787 |
| 2 | NTRK3 | 3.58826190 |
| 3 | MAP3K9 | 2.98296330 |
| 4 | MAP3K4 | 2.89044376 |
| 5 | CASK | 2.85509385 |
| 6 | NTRK2 | 2.76478533 |
| 7 | MINK1 | 2.68537672 |
| 8 | MAP2K7 | 2.58894195 |
| 9 | INSRR | 2.52084113 |
| 10 | EPHA4 | 2.49201733 |
| 11 | MAPK13 | 2.20334253 |
| 12 | SIK2 | 2.08707517 |
| 13 | DAPK2 | 2.08269082 |
| 14 | MAP2K4 | 1.95311151 |
| 15 | MAP3K12 | 1.90598267 |
| 16 | PAK6 | 1.90113911 |
| 17 | RIPK4 | 1.85818920 |
| 18 | TNIK | 1.82582821 |
| 19 | PNCK | 1.78693813 |
| 20 | NTRK1 | 1.65923559 |
| 21 | LATS2 | 1.65616350 |
| 22 | PHKG1 | 1.64838018 |
| 23 | PHKG2 | 1.64838018 |
| 24 | KSR1 | 1.63422694 |
| 25 | PRPF4B | 1.58971184 |
| 26 | DYRK2 | 1.54889458 |
| 27 | DYRK3 | 1.44469379 |
| 28 | KSR2 | 1.44335689 |
| 29 | CDK5 | 1.43566377 |
| 30 | EPHB2 | 1.42659714 |
| 31 | CAMKK1 | 1.35623941 |
| 32 | TRIM28 | 1.34207335 |
| 33 | UHMK1 | 1.29949210 |
| 34 | PLK2 | 1.28110893 |
| 35 | FRK | 1.25495712 |
| 36 | DAPK1 | 1.20069789 |
| 37 | PINK1 | 1.17796848 |
| 38 | PRKCG | 1.12190503 |
| 39 | AKT3 | 1.11457754 |
| 40 | ERBB3 | 1.09917170 |
| 41 | MAP3K6 | 1.08929900 |
| 42 | CAMKK2 | 1.05882155 |
| 43 | DYRK1A | 1.04128672 |
| 44 | PLK4 | 1.03186644 |
| 45 | GRK5 | 1.03057329 |
| 46 | FES | 0.97957993 |
| 47 | NME1 | 0.94883836 |
| 48 | CSNK1G2 | 0.93441293 |
| 49 | MAP3K2 | 0.92627308 |
| 50 | PKN1 | 0.92575639 |
| 51 | GRK1 | 0.92321893 |
| 52 | CDK19 | 0.91819732 |
| 53 | CAMK2A | 0.91027849 |
| 54 | PAK3 | 0.90028928 |
| 55 | CDK14 | 0.87708275 |
| 56 | RPS6KA2 | 0.86601633 |
| 57 | ERBB4 | 0.86161747 |
| 58 | ACVR1B | 0.85686004 |
| 59 | CDK18 | 0.84288072 |
| 60 | CDK15 | 0.81888511 |
| 61 | ICK | 0.81815207 |
| 62 | PIK3CA | 0.79495720 |
| 63 | EIF2AK1 | 0.78767666 |
| 64 | CAMK2B | 0.78297626 |
| 65 | MARK2 | 0.77269705 |
| 66 | PIM2 | 0.76621439 |
| 67 | DYRK1B | 0.75865362 |
| 68 | EPHA3 | 0.75424768 |
| 69 | RET | 0.74413030 |
| 70 | SGK494 | 0.73586429 |
| 71 | SGK223 | 0.73586429 |
| 72 | CDK11A | 0.71469565 |
| 73 | CAMK1G | 0.68513096 |
| 74 | MAP4K2 | 0.68472015 |
| 75 | BMPR2 | 0.64599644 |
| 76 | PRKCZ | 0.63902094 |
| 77 | STK38 | 0.63325584 |
| 78 | BCR | 0.61610093 |
| 79 | TYRO3 | 0.60638566 |
| 80 | CCNB1 | 0.60157077 |
| 81 | CAMK2G | 0.59567755 |
| 82 | CSNK1G1 | 0.59529322 |
| 83 | LIMK1 | 0.59269655 |
| 84 | STK11 | 0.58217740 |
| 85 | CAMK1 | 0.57434436 |
| 86 | MAP3K5 | 0.56608040 |
| 87 | SGK2 | 0.56375157 |
| 88 | ALK | 0.55296100 |
| 89 | MUSK | 0.55167535 |
| 90 | ZAK | 0.55127880 |
| 91 | MAPK12 | 0.55085377 |
| 92 | BMPR1B | 0.53881443 |
| 93 | OXSR1 | 0.52894562 |
| 94 | PRKCE | 0.51700777 |
| 95 | SGK1 | 0.51685676 |
| 96 | CSNK1E | 0.50337651 |
| 97 | PTK6 | 0.49799361 |
| 98 | PRKACA | 0.48348322 |
| 99 | BCKDK | 0.47450704 |
| 100 | RAF1 | 0.46407514 |
| 101 | CSNK1G3 | 0.45466972 |
| 102 | RPS6KB1 | 0.44186841 |
| 103 | MAP2K1 | 0.44185886 |
| 104 | ERBB2 | 0.43073685 |
| 105 | PRKACB | 0.42080149 |
| 106 | CAMK4 | 0.40326506 |
| 107 | SIK3 | 0.40154209 |
| 108 | SCYL2 | 0.40073345 |
| 109 | ADRBK1 | 0.39182947 |
| 110 | FYN | 0.39026075 |
| 111 | CAMK2D | 0.39009931 |
| 112 | RPS6KA3 | 0.38766002 |
| 113 | MAPK9 | 0.38384980 |
| 114 | PASK | 0.37840986 |
| 115 | CSNK1D | 0.37781978 |
| 116 | WNK3 | 0.36689530 |
| 117 | FER | 0.36243913 |
| 118 | DAPK3 | 0.35868470 |
| 119 | PRKG1 | 0.35437896 |
| 120 | CSNK1A1L | 0.35052685 |
| 121 | PTK2B | 0.35044044 |
| 122 | DMPK | 0.34653825 |
| 123 | MAPK4 | 0.34197635 |
| 124 | PRKCB | 0.33983212 |
| 125 | FGFR2 | 0.33955942 |
| 126 | PRKDC | 0.33925910 |
| 127 | LMTK2 | 0.32894517 |
| 128 | MAPK10 | 0.31711226 |
| 129 | ARAF | 0.31539286 |
| 130 | ROCK2 | 0.31467073 |
| 131 | PRKCH | 0.30623980 |
| 132 | FGR | 0.30113811 |
| 133 | SGK3 | 0.30048053 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.75012202 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.15367014 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.86861154 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.82190686 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.80714030 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 2.55856859 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.53352199 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.49062253 |
| 9 | Olfactory transduction_Homo sapiens_hsa04740 | 2.47967316 |
| 10 | Protein export_Homo sapiens_hsa03060 | 2.41549554 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.25539632 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.22842293 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.18579888 |
| 14 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.09694812 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.06069386 |
| 16 | Long-term depression_Homo sapiens_hsa04730 | 2.05078370 |
| 17 | Salivary secretion_Homo sapiens_hsa04970 | 1.92651789 |
| 18 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.90086702 |
| 19 | Taste transduction_Homo sapiens_hsa04742 | 1.89629958 |
| 20 | Insulin secretion_Homo sapiens_hsa04911 | 1.84303094 |
| 21 | Renin secretion_Homo sapiens_hsa04924 | 1.70339831 |
| 22 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.70038685 |
| 23 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.66784794 |
| 24 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.64192355 |
| 25 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.58208509 |
| 26 | Axon guidance_Homo sapiens_hsa04360 | 1.57990893 |
| 27 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.57014829 |
| 28 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.53810974 |
| 29 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.51524142 |
| 30 | Cocaine addiction_Homo sapiens_hsa05030 | 1.51106342 |
| 31 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.50540730 |
| 32 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.46390222 |
| 33 | Gap junction_Homo sapiens_hsa04540 | 1.46165847 |
| 34 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.42959103 |
| 35 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.41011820 |
| 36 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.37534191 |
| 37 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.36784826 |
| 38 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.32670117 |
| 39 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.27418362 |
| 40 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.24150467 |
| 41 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.21610731 |
| 42 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.21215536 |
| 43 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.17240212 |
| 44 | Huntingtons disease_Homo sapiens_hsa05016 | 1.15570957 |
| 45 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.14321157 |
| 46 | Glioma_Homo sapiens_hsa05214 | 1.13375761 |
| 47 | Melanogenesis_Homo sapiens_hsa04916 | 1.12070114 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.10110842 |
| 49 | RNA polymerase_Homo sapiens_hsa03020 | 1.08895395 |
| 50 | Phototransduction_Homo sapiens_hsa04744 | 1.08213876 |
| 51 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.07832078 |
| 52 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.03201302 |
| 53 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.01109454 |
| 54 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.00101338 |
| 55 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.99566315 |
| 56 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.99532801 |
| 57 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.98883564 |
| 58 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.98487005 |
| 59 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.98479270 |
| 60 | Basal transcription factors_Homo sapiens_hsa03022 | 0.98202955 |
| 61 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.92922426 |
| 62 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.90902797 |
| 63 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.87282979 |
| 64 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.85538667 |
| 65 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.83918491 |
| 66 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.83848770 |
| 67 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.78610414 |
| 68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78152203 |
| 69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.76871419 |
| 70 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.75198602 |
| 71 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.74393950 |
| 72 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.73959896 |
| 73 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.72058352 |
| 74 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70324920 |
| 75 | Endometrial cancer_Homo sapiens_hsa05213 | 0.69597799 |
| 76 | Alzheimers disease_Homo sapiens_hsa05010 | 0.69115844 |
| 77 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69021032 |
| 78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67875852 |
| 79 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.64724749 |
| 80 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.64343006 |
| 81 | Alcoholism_Homo sapiens_hsa05034 | 0.63122666 |
| 82 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.62225572 |
| 83 | Prion diseases_Homo sapiens_hsa05020 | 0.61834282 |
| 84 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61606993 |
| 85 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.61572016 |
| 86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.60804439 |
| 87 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.60706382 |
| 88 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.59645849 |
| 89 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.59601089 |
| 90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59076097 |
| 91 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.57605913 |
| 92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.56274007 |
| 93 | Circadian rhythm_Homo sapiens_hsa04710 | 0.56164445 |
| 94 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.55900625 |
| 95 | Colorectal cancer_Homo sapiens_hsa05210 | 0.55640292 |
| 96 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.55193759 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.53864472 |
| 98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53412991 |
| 99 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.53377343 |
| 100 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.53022520 |
| 101 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52477846 |
| 102 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52476924 |
| 103 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50254493 |
| 104 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.49791931 |
| 105 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.49604455 |
| 106 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48686405 |
| 107 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.48316814 |
| 108 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.47643715 |
| 109 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.47482041 |
| 110 | Ribosome_Homo sapiens_hsa03010 | 0.47345988 |
| 111 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.45810133 |
| 112 | Tight junction_Homo sapiens_hsa04530 | 0.45648344 |
| 113 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.44965272 |
| 114 | Peroxisome_Homo sapiens_hsa04146 | 0.44566213 |
| 115 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.43511070 |
| 116 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.43332329 |
| 117 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.42231338 |
| 118 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.42077630 |
| 119 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.40566105 |
| 120 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.39989589 |
| 121 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38900648 |
| 122 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.38799466 |
| 123 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.38220985 |
| 124 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.38173984 |
| 125 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.38053478 |
| 126 | Endocytosis_Homo sapiens_hsa04144 | 0.37506453 |
| 127 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.37431323 |
| 128 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.37024750 |
| 129 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.36862026 |
| 130 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.36110165 |
| 131 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.35860627 |
| 132 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33850798 |
| 133 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.32281188 |
| 134 | Parkinsons disease_Homo sapiens_hsa05012 | 0.32097761 |
| 135 | Bile secretion_Homo sapiens_hsa04976 | 0.28899117 |
| 136 | Phagosome_Homo sapiens_hsa04145 | 0.28698266 |
| 137 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.26836086 |

